FORMULATION AND CHARACTERIZATION OF ISRADIPINE SOLID DISPERSION WITH ENHANCED SOLUBILITY

ZAID HADI FAKHRULDEEN; MAZIN THAMIR  ABDUL-HASAN

doi:10.22159/ijap.2025v17i1.52230

Authors

ZAID HADI FAKHRULDEEN Al-Najaf Health Directorate, Najaf, Iraq https://orcid.org/0009-0004-2258-8009
MAZIN THAMIR ABDUL-HASAN Department of Pharmaceutics, Faculty of Pharmacy, University of Kufa, Najaf, Iraq https://orcid.org/0000-0001-7682-838X

DOI:

https://doi.org/10.22159/ijap.2025v17i1.52230

Keywords:

Poloxamer 407, Isradipine, Dissolution rate, Solubility, Solid dispersion, polymer, Solvent evaporation

Abstract

Objective: This study aimed to prepare and optimize solid dispersion of isradipine, an antihypertensive drug with poor aqueous solubility using two different methods, namely, solvent evaporation and fusion.

Methods: Twenty-two formulas of isradipine solid dispersion were prepared using one of the following carriers: Poloxamer 407 (PXM 407), Polyethylene Glycol 4000 (PEG 4000), Polyethylene Glycol 6000 (PEG 6000) and urea at different carrier-to-drug ratios. The produced solid dispersion formulations were evaluated for their percentage yield, drug content, solubility, and in vitro dissolution. Further investigations were performed for the selected formula; these include Differential Scanning Calorimetry (DSC), and Powder X-Ray Diffraction (PXRD) studies to evaluate the crystalline state of the drug. Besides Fourier Transformation Infrared (FTIR) spectroscopy was conducted to evaluate drug-carrier compatibility.

Results: The results of this study showed that all the prepared formulas resulted in improvement in saturation solubility. Run 14 (which consists of PXM 407: isradipine in a 5:1 ratio) demonstrated a substantial increase in solubility, resulting in approximately 16 times higher solubility than the pure drug. The results of DSC and PXRD studies demonstrated complete dispersion of the drug in the carrier or amorphization of the drug. Furthermore, FTIR results indicated drug-carrier compatibility.

Conclusion: From this study, it was evident that solid dispersion of isradipine in the previously mentioned carriers is an effective and efficient method to enhance its solubility. The best solubility enhancement and release profile was observed in run 14 (which combines PXM 407: isradipine in a 5:1 ratio), which was selected as the optimum formula.

Downloads

Download data is not yet available.

References

Boyd BJ, Bergström CAS, Vinarov Z, Kuentz M, Brouwers J, Augustijns P, et al. Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems. Eur J Pharm Sci. 2019 Sep 1; 137:104967.

Kumar S, Bhargava D, Thakkar A, Arora S. Drug carrier systems for solubility enhancement of BCS class II drugs: A critical review. Crit Rev Ther Drug Carrier Syst. 2013 Apr 24;30(3):217–256.

Neal L. Benowitz. Antihypertensive agents. In Katzung B,Trevor A. Basic and clinical pharmacology: New York: McGraw-Hill; 2015.

Moffat A, Osselton M, Widdop B. Clarke,s analysis of drug and poisons. 4th ed. London: The Pharmaceutical Press; 2011.

Ramasahayam B, Eedara BB, Kandadi P, Jukanti R, Bandari S. Development of isradipine loaded self-nano emulsifying powders for improved oral delivery: In vitro and in vivo evaluation. Drug Dev Ind Pharm. 2015 May;41(5):753–763.

Ainurofiq A, Putro DS, Ramadhani DA, Putra GM, Do Espirito Santo LDC. A review on solubility enhancement methods for poorly water-soluble drugs. J Rep Pharm Sci. 2012 May 31;10(1):137–147.

Bhujbal S V., Mitra B, Jain U, Gong Y, Agrawal A, Karki S, et al. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharm Sin B. 2021 Aug 1;11(8):2505–2536.

Sharma B. Drugs Dissolution Enhancement by Using Solid Dispersion Technique: A Review. EPRA Int. J. Multidiscip. Res. 2021 Jan;7(1):1–2.

Kandwal M, Ghalan I, Patil S. Formulation and Evaluation of Nimodipine Tablets Using Solid Dispersion Technique. Asian Pac J Health Sci. 2022 Jun 20;9(4):355–364.

Mohana M, Vijayalakshmi S. Development and characterization of solid dispersion-based orodispersible tablets of cilnidipine. Beni-Suef Univ J Basic Appl Sci. 2022 Dec 1;11(1):83-94.

Sarkar P, Majee SB. Formulation Development and In-vitro characterization of ternary hydrotropic solid dispersions of aceclofenac. Asian J Pharm Clin Res. 2022 Jun 13;15(9):174-179.

Mankar SD, Rachh PR. Formulation, Development, Evaluation and Solubility Enhancement of Lercanidipine Hydrochloride by Solid Dispersion Techniques. J Pharm Res Int. 2021 Dec 7;33(53B)195–213.

Tripathi D, Sharma K, Sahoo J, Chaudhary N. A Recent Advancement in Approaches used for Estimation of Drug Solubility: A Review. Der Pharm Lett. 2020;12(4):15–29.

Pharmacopoeia B. British pharmacopoeia. 2016.

Muselík J, Komersová A, Kubová K, Matzick K, Skalická B. A critical overview of FDA and EMA statistical methods to compare in vitro drug dissolution profiles of pharmaceutical products. Pharmaceutics. 2021Oct 1;13(10):1703-1715

Al-Edresi S, Hamrah KA, Al-Shaibani A. Formulation and validation of Candesartan cilexetil-loaded nanosuspension to enhance solubility. Pharmacia. 2024 Mar 19; 71:1–13.

Wannas AN, Abdul-Hasan MT, Jawad KKM, Razzaq IFA. Preparation and In Vitro Evaluation of Self-Nano Emulsifying Drug Delivery Systems of Ketoprofen. Int. J. Appl. Pharm. 2023 May 1;15(3):71–79.

Sopyan I, Raihan Riyaldi M, Ratnawulan Mita S, Hariono M. Increasing Solution in the Drug Simvastatin with Solid Dispersion Technique Using Polymer Soluplus. Int. J. Appl. Pharm. 2023 Jul 1;15(4):160–165.

Vo CLN, Park C, Lee BJ. Current trends and future perspectives of solid dispersions containing poorly water-soluble drugs. Eur J Pharm Biopharm. 2013 Nov;85(3 PART B):799–813.

Nair AR, Lakshman YD, Anand VSK, Sree KSN, Bhat K, Dengale SJ. Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology. AAPS Pharm SciTech. 2020 Nov 8;21(8):309-329.

Szafraniec J, Antosik A, Knapik-Kowalczuk J, Chmiel K, Kurek M, Gawlak K, et al. Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress. Int. J. Pharm. 2018 May 5;542(1–2):18–26.

Abduljabbar HH, Abd Alhammid SN. Enhancement of the Solubility and the Dissolution Rate of Tamoxifen Citrate Solid Dispersion Using Soluplus by Solvent Evaporation Technique. Asian J Pharm Clin Res. 2019 Jan 7;12(1):216-221.

Sarisuta N, Parrott EL. Relationship of Dissolution Rate to Viscosity of Polymeric Solutions. J. Pharm. Sci. 1982 1(12):1375–1380.

Beneš M, Pekárek T, Beránek J, Havlíček J, Krejčík L, Šimek M, et al. Methods for the preparation of amorphous solid dispersions – A comparative study. J Drug Deliv Sci Technol. 2017 Apr 1; 38:125–134.

Eloy JO, Marchetti JM. Solid dispersions containing ursolic acid in Poloxamer 407 and PEG 6000: A comparative study of fusion and solvent methods. Powder Technology. 2014 Feb; 253:98–106.

Hussien RM, Ghareeb MM. Formulation and Characterization of Isradipine Nanoparticle for Dissolution Enhancement. Iraqi J Pharm Sci. 2021Jun19;30(1):218–225.

Ghose D, Patra CN, Swain S, Sruti J. Box-Behnken Design-Based Development and Characterization of Polymeric Freeze-Dried Nanoparticles of Isradipine for Improved Oral Bioavailability. Int. J. Appl. Pharm. 2023 Jul 1;15(4):60–70.

Tran TTD, Tran PHL. Investigation of polyethylene oxide-based prolonged release solid dispersion containing isradipine. J Drug Deliv Sci Technol. 2013;23(3):269–74.

Sadoon NA, Ghareeb MM. Formulation and characterization of isradipine as oral nanoemulsion. Iraqi J Pharm Sci. 2020 Jun 25;29(1):143–153.

Meruva S, Thool P, Shah S, Karki S, Bowen W, Ghosh I, et al. Formulation and performance of Irbesartan nanocrystalline suspension and granulated or bead-layered dried powders – Part I. Int J Pharm. 2019 Sep 10; 568:118189.

Simonazzi A, Davies C, Cid AG, Gonzo E, Parada L, Bermúdez JM. Preparation and Characterization of Poloxamer 407 Solid Dispersions as an Alternative Strategy to Improve Benznidazole Bioperformance. J Pharm Sci. 2018 Nov 1;107(11):2829–2836.